HER2 based subtyping of metastatic breast cancer: clinical and molecular characteristics
Senologie(2023)
Abstract
Zielsetzung The question of whether HER2-low constitutes a distinct breast cancer (BC) sub-entity with specific clinical and molecular features remains unresolved.
MoreTranslated text
Key words
metastatic breast cancer,her2
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined